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Molecular mechanisms governing the maintenance and proliferation of dorsal root ganglia (DRG)
progenitors are largely unknown. Here we reveal that the Hippo pathway regulates the expansion of
DRG progenitors and glia during mammalian DRG development. The key effectors of this pathway,
transcriptional coactivators Yap and Taz, are expressed in DRG progenitors and glia during DRG
development but are at least partially inhibited from activating transcription. Aberrant YAP activation
leads to overexpansion of DRG progenitor and glial populations. We further show that the Neuroﬁ-
bromatosis 2 (Nf2) tumor suppressor inhibits Yap during DRG development. Loss of Nf2 leads to similar
phenotypes as does YAP hyperactivation, and deleting Yap suppresses these phenotypes. Our study
demonstrates that Nf2–Yap signaling plays important roles in controlling the expansion of DRG
progenitors and glia during DRG development.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The dorsal root ganglia (DRG) are clusters of sensory neurons and
glia found at the dorsal root of the spinal nerves. They transmit
sensory information from the body to the central nervous system
(CNS) (Zigmond et al., 1999). Neurons and glia in the DRG are derived
from neural crest (NC) cells, whose precursors reside within the dorsal
neural tube (Le Douarin and Smith, 1988). Upon delaminating from
the neural tube around embryonic day (E) 8.5 in mice, some NC cells
migrate ventrally between somites and the neural tube and coalesce
to generate the DRG (Frank and Sanes, 1991; Serbedzija et al., 1992).
During migration and after condensation into a ganglion, multipotent
NC cells (here we refer to the migrating ones as migratory NC cells
and those within the DRG as DRG progenitors) become committed to
neuronal or glial fates and give rise to sensory neurons and satellite
glia in DRG (Frank and Sanes, 1991; Ma et al., 1999; Rifkin et al., 2000;
Serbedzija et al., 1992). In mice, starting from around E9.5, a subset of
multipotent NC cells give rise to sensory neurons in DRG in two
temporally distinct but overlapping waves, which are regulated
by basic helix-loop-helix transcription factors Neurogenin (Ngn) 2
and Ngn1 (Ma et al., 1999; Rifkin et al., 2000). The ﬁrst wave of
neurogenesis, dependent on Ngn2 activity, is completed by E11.5 in
mice and mostly gives rise to large-diameter neurotrophic tyrosine
kinase receptor (Trk) B-positive (TrkBþ) mechanoceptive and TrkCþ
proprioceptive neurons. Ngn1-dependent second wave of neurogen-
esis occurs between E10.5 and E13.5 and mainly produces small-
diameter TrkAþ nociceptive neurons (Marmigère and Ernfors, 2007).
All sensory neurons express markers Isl1/2 and Tuj1. Satellite glia are
ﬁrst detected around E11 by the early glial marker brain lipid binding
protein (Blbp) (Kurtz et al., 1994). Although factors regulating
DRG neurogenesis and gliogenesis have been studied extensively
(Marmigère and Ernfors, 2007; Woodhoo and Sommer, 2008), those
governing the maintenance and proliferation of multipotent DRG
progenitors are largely unknown.
The Hippo pathway is an evolutionarily conserved signaling
pathway that regulates organ growth and tumorigenesis (Yu and
Guan, 2013; Zhao et al., 2011). Central to this pathway are kinases
Mst1/2 and Lats1/2, which phosphorylate transcriptional coacti-
vators Yap and Taz (here referred to as Yap/Taz), resulting in their
cytoplasmic retention. Inactivation of Mst1/2 or Lats1/2 kinases or
overexpression of Yap leads to accumulation of unphosphorylated
Yap, which translocates into the nucleus and activates genes that
promote proliferation and survival. Nf2/Merlin is an upstream
activator of the Hippo pathway (Hamaratoglu et al.,2006; Milton et
al., 2010; Zhang et al., 2010). Encoded by the tumor suppressor
gene Neuroﬁbromatosis 2, Nf2 is a close relative of the Ezrin/
Radixin/Moesin (ERM) protein family, which links the cytoskele-
ton to membrane proteins (Bretscher et al., 2002). In addition to its
functions in maintaining cell–cell contact and cell polarity, Nf2
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mediates contact-dependent inhibition of cell proliferation in vitro
and controls tissue homeostasis and tumorigenesis in vivo (Li et al.,
2012).
The Hippo-Yap/Taz pathway controls self-renewal and expansion
of mouse and human embryonic stem cells (Lian et al., 2010; Varelas
et al., 2008) and tissue-speciﬁc stem/progenitor cells (Camargo et al.,
2007; Lee et al., 2010; Zhang et al., 2010). We previously showed
that Yap regulates neural progenitor cell number during vertebrate
CNS development (Cao et al., 2008) and recently found that Nf2
inhibits Yap/Taz to limit the expansion of the neural progenitor pool
during mammalian brain development (Lavado et al., 2013). In
Drosophila, the Yap ortholog Yki promotes the expansion of optic
lobe neuroepithelial and glial cells (Reddy and Irvine, 2011; Reddy
et al., 2010). Taken together, these studies establish Yap as an
important regulator of the sizes of CNS neural progenitor and glial
populations.
Here we investigated the function of Yap and Nf2 during mouse
DRG development. We found that Yap/Taz are expressed in migra-
tory NC cells, DRG progenitors, and the glial lineage but not in the
neuronal lineage. Elevation of YAP expression in DRG progenitors
and glial cells expands these cell populations. Furthermore, we
found that Nf2 inhibits Yap during DRG development. In the absence
of Nf2, the numbers of DRG progenitors and glial cells are increased
and that of neurons is reduced, mimicking the phenotypes of YAP
gain-of-function mutants. Deletion of Yap in the Nf2 conditional
knockout (cKO) background suppresses these phenotypes. We
further show that Nf2–Yap signaling regulates progenitor expansion
during the development of another NC derivative, the sympathetic
ganglia (SG), in a similar fashion. Our ﬁndings provide novel insights
into the function of Nf2–Yap signaling during NC development.
Materials and methods
Animals
All animal experiments were performed in accordance with the
guidelines set by the Institutional Animal Care and Use Committee
of St. Jude Children’s Research Hospital (SJCRH). The TetO-YAP line
(Camargo et al., 2007) was provided by Thijn R. Brummelkamp and
Fernando D. Camargo (Children’s Hospital, Boston, MA). Sox10-rtTA
line (Ludwig et al., 2004) was a gift from Michael Wegner
(Universität Erlangen-Nürnberg, Erlangen, Germany). Wnt1-Cre
(Stock No: 007807) and Axin2-rtTA (Stock No: 016997) lines were
obtained from the Jackson Laboratory. The YapFlox/Flox line (Xin et al.,
2011) was provided by Eric N. Olson (University of Texas South-
western Medical Center, Dallas, TX). The Nf2Flox/Flox line has been
described previously (Giovannini et al., 2000). An Nf2Δ allele was
generated by breeding Nf2Flox/Flox mice with the Ella-Cre line (Stock
No: 003724, Jackson Laboratory). As both Nf2 and Wnt1-Cre are on
Chromosome 11, a recombined allele, Nf2Δ;Wnt1-Cre, was generated
by extensive breeding. For BrdU pulse-labeling, timed pregnant
mice were given intraperitoneal injections of BrdU (10 mg/ml in
0.9% saline) at a dose of 100 mg/kg. Doxycycline was delivered in
drinking water at 500 mg/l at the time points indicated.
Histology and immunostaining
Embryos younger than E15.5 were ﬁxedwith 4% paraformaldehyde
in PBS overnight at 4 1C. Embryos at E15.5 or older were intracardially
perfused with 4% paraformaldehyde and post-ﬁxed overnight at 4 1C.
Samples were embedded in OCT and sectioned at 16-μm thickness.
Immunostainings were performed according to standard protocols.
Primary antibodies were as follows: Blbp (Millipore, ABN14; rabbit,
1:500), BrdU (Abcam, ab6326; rat, 1:100), Isl1/2 (Developmental
Studies Hybridoma Bank, Clone # 39.4D5; mouse, 1:500), Ki67 (Vector
Laboratories, VP-RM04; rabbit, 1:250), Nf2 (Sigma, HPA003097; rabbit,
1:1000 and ampliﬁcation with Invitrogen TSA kit), p75 (Promega,
G3231; rabbit, 1:2000), S100β (Sigma, S2532; mouse, 1:100 and
ampliﬁcation with Invitrogen TSA kit), Sox10 (Santa Cruz, sc-17342;
goat, 1:250), TrkA (provided by Louis Reichardt, University of Califor-
nia, San Francisco, CA; rabbit, 1:1000), Tuj1 (Covance, MMS-435P;
mouse, 1:1000), Yap/Taz (Cell Signaling, 8418; rabbit, 1:200 and
ampliﬁcation with Invitrogen TSA kit), and pYap (Cell Signaling,
4911; rabbit, 1:200). Secondary antibodies were from Invitrogen and
Jackson ImmunoResearch. Fluorescent images were acquired with a
Zeiss LSM 510 or 780 confocal microscope.
Western blot analysis
DRG were dissected from E13.5 embryos. Total DRG lysates
were prepared in 20 mM HEPES (pH 7.4), 150 mM NaCl, 2% SDS,
and 5% glycerol supplemented with the Halt protease and phos-
phatase inhibitor cocktail (Thermo Scientiﬁc). The following pri-
mary antibodies were used: Nf2 (Sigma, HPA003097; rabbit,
1:1000) and GAPDH (Sigma, G8795, mouse; 1:10,000).
In situ hybridization
In situ hybridization was performed as described (Schaeren-
Wiemers and Gerﬁn-Moser, 1993). Ngn1 probe was provided by
Andy Groves (Baylor College of Medicine Houston, TX) (Raft et al.,
2007). Ngn2 and TrkB probes were provided by Qiufu Ma (Harvard
Medical School, Boston, MA) (Ma et al., 1999). A probe speciﬁc for
the TrkC tyrosine kinase domain was designed based on Fagan
et al., 1996. Total RNA was extracted from E13.5 wild-type mouse
brain using TRIzol reagent (Invitrogen) and reverse transcribed by
using the SuperScript III cDNA kit (Invitrogen). A 738 bp-long
cDNA fragment encoding a portion of the kinase domain was
ampliﬁed using forward primer CATCAAGAGGAGAGATATCGTGTT-
GAAGAG and reverse primer GGTCTCTTCTAGACACGGCC, where
italics sequences show the restriction enzyme sites integrated into
the fragment by PCR (EcoRV and XbaI, respectively). The fragment
was cloned into pBluescript plasmid at EcoRV and XbaI sites.
Antisense probe was generated by linearizing the vector with
EcoRV and transcribing with T3 RNA polymerase. Images were
acquired with a Zeiss Axio Imager M2 microscope equipped with a
Zeiss AxioCam MRc camera.
Quantiﬁcation and statistical analysis
Cell counting was performed using the ImageJ software. Three
embryos for each genotype were quantiﬁed. Quantiﬁcations were
performed on sections at similar rostrocaudal levels. Absolute num-
bers shown in bar graphs are mean number of cells per section. All
values shown are mean7s.e.m. P-values were calculated with two-
tailed, unpaired t-test.
Results
Yap/Taz expression pattern in the developing DRG
To begin investigating the potential function of the Hippo path-
way during DRG development, we ﬁrst examined the expression
pattern of Yap/Taz in mouse embryos using an antibody that
recognizes both Yap and Taz. At E9.5, Yap/Taz were detected in
Sox10þ migrating NC cells (Kuhlbrodt et al., 1998; Paratore et al.,
2001) (Fig. 1A). At E10.5, when migrating NC cells have coalesced into
the forming DRG, Yap/Taz were expressed in all Sox10þ cells (Fig. 1C),
a population consisting of p75þ DRG progenitors (Fig. 1D, arrow-
heads) and p75– glial precursors which retain Sox10 expression but
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have not yet started expression of the glial marker Blbp (Hu et al.,
2011; Sonnenberg-Riethmacher et al., 2001) (Fig. 1D, arrows). Cells of
the neuronal lineage, marked by Isl1/2, did not express Yap/Taz
(Fig. 1E), whether they were proliferating BrdUþ neuronal precursors
(Fig. 1E, arrowheads, 2-h BrdU pulse) or BrdU– postmitotic neurons
(Fig. 1E, arrows). At E15.5, Yap/Taz expression persisted in Sox10þ
cells (Fig. 1G and G0), almost all of which coexpressed the glial
marker Blbp at this stage (Fig. 1H and H0). Neurons, marked by Tuj1,
did not express Yap/Taz (Fig. 1I and I0). In summary, during mouse
DRG development, Yap/Taz are expressed in migratory NC cells, DRG
progenitors, glial precursors, and satellite glia, but not in neuronal
precursors or post-mitotic neurons.
Throughout the developmental stages examined, Yap/Taz were
present in the cytoplasm (Fig. 1A, C, G and G0), suggesting that
their transcriptional activity is at least partially inhibited. Indeed,
the S112-phosphorylated form of Yap (S127 in human YAP), which
Fig. 1. Yap/Taz are expressed in migratory NC cells, DRG progenitors, glial precursors, and satellite glia during DRG development. (A) At E9.5, Yap/Taz are expressed in
Sox10þ migratory NC cells. Two cells marked by arrowheads are magniﬁed in the inset. (C–E) At E10.5, Yap/Taz are expressed in Sox10þ cells (C) consisting of p75þ DRG
progenitors (D, arrowheads, lower left corner inset) and p75– glial precursors (D, arrows, upper right corner inset). Neuronal precursors (E, arrowheads, Isl1/2þBrdUþ , 2-h
BrdU pulse) or postmitotic neurons (E, arrows, Isl1/2þBrdU) do not express Yap/Taz. (G–I0) At E15.5, Yap/Taz are expressed in Sox10þ cells (G and G0), almost all of which
coexpress the glial marker Blbp (H and H'). Tuj1þ neurons do not express Yap/Taz (I and I'). (B, F, J and J') S112-phosphorylated form of Yap (pYap) is detected in Sox10þ cells
at each stage. Dashed lines in A and B mark the neural tube (NT) border. Panels labeled with primes are the magniﬁed view of the boxed areas in corresponding panels. Scale
bars: 25 μm in A, G0; 50 μm in C; 100 μm in G.
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is the product of the Hippo kinase cascade and is unable to activate
transcription, was readily detectible in Sox10þ cells at each stage
(Fig. 1B, F, J and J0).
YAP overexpression in NC precursors, migratory NC cells, and DRG
progenitors leads to overexpansion of DRG progenitors
To understand the functional signiﬁcance of keeping Yap/Taz
suppressed, we decided to examine the consequences of their
aberrant activation on DRG development. To this end, we utilized a
mouse line that carries a doxycycline (Dox)-dependent allele of
human YAP1 (TetO-YAP1S127A, here referred to as TetO-YAP)
(Camargo et al., 2007). Mating these mice with those expressing
the tetracycline-dependent transactivator rtTA under the control
of the Axin2 promoter (Axin2-rtTA) (Yu et al., 2007) and providing
dams with Dox enable overexpression of the S127A mutant
version of YAP, which presumably has enhanced nuclear localiza-
tion compared to the wild-type protein due to the lack of
phosphorylation and therefore inhibition by the Hippo kinase
cascade. The Axin2 promoter is active in NC precursors within
the dorsal neural tube starting at E8.5 and in migratory NC cells
(Yu et al., 2007). To examine the effect of YAP overexpression at
early stages of DRG development, we gave Dox-containing water
to pregnant females starting from E5.5. At E10.5, YAP was over-
expressed in the DRG of TetO-YAP;Axin2-rtTA double transgenic
embryos and the overexpression was restricted to Sox10þp75þ
DRG progenitors (Fig. 2A–D0, arrowheads) and Sox10þp75 glial
precursors (A–D0, arrows). At E12.5, YAP was no longer over-
expressed in TetO-YAP;Axin2-rtTA DRG (Fig. 2E and F) despite the
presence of Dox, which is likely due to the downregulation of the
Axin2 promoter. Thus, TetO-YAP;Axin2-rtTA embryos experienced
elevated YAP activity in NC precursors, migratory NC cells, DRG
progenitors, and glial precursors before E12.5.
At E10.5, the DRG of TetO-YAP;Axin2-rtTA embryos contained
signiﬁcantly more Sox10þp75þ DRG progenitors (Fig. 2G–I) than
did the DRG of control embryos. To determine the cellular basis
underlying these phenotypes, we analyzed the proliferation of
DRG progenitors. We labeled S-phase cells with BrdU 2 h before
harvesting the embryos and quantiﬁed the percentage of BrdUþ
DRG progenitors (BrdUþSox10þp75þ , Fig. 2J–K0, arrowheads)
within the progenitor population (Sox10þp75þ). The fraction of
proliferating (BrdUþ) DRG progenitors was markedly higher in
TetO-YAP;Axin2-rtTA embryos than in controls (Fig. 2L). To measure
cell-cycle exit, we labeled S-phase cells with BrdU 24 h prior to
harvesting the embryos and quantiﬁed the fraction of BrdUþ cells
that no longer expressed the proliferating-cell marker Ki67
(BrdUþKi67–/BrdUþ cells) (Fig. 2M–N0), which indexes the frac-
tion of cells that have exited the cell-cycle within the past 24-h
period. Cell-cycle exit was signiﬁcantly reduced in TetO-YAP;Axin2-
rtTA DRG (Fig. 2O). Taken together, these results demonstrate
that YAP augments the proliferation capacity of DRG progenitors
during the early stages of DRG development.
To determine whether YAP hyperactivation at early stages of
DRG development affects neurogenesis, we examined the neuro-
nal population at two stages of DRG development. At E10.5, TetO-
YAP;Axin2-rtTA DRG contained fewer Isl1/2þ neurons (Fig. 3A, B
and G) than did the DRG of control embryos. The number of TrkCþ
neurons was signiﬁcantly reduced whereas the numbers of TrkAþ
or TrkBþ neurons were unchanged in TetO-YAP;Axin2-rtTA DRG
(Fig. 3H– N). At postnatal day 0 (P0), when YAP was no longer
overexpressed in TetO-YAP;Axin2-rtTA DRG (Fig. 3C and D),
both the total number of neurons (Fig. 3E–G) and the numbers
of each subtype of neurons (Fig. 3O–U) were restored to control
levels. These results suggest that YAP hyperactivation at early
stages of DRG development delays the production of TrkCþ
neurons.
YAP overexpression in DRG progenitors and glial cells expands these
populations
Because the Axin2 promoter was downregulated in DRG by
E12.5 (Fig. 2E and F), we were unable to analyze the effect of
aberrant YAP activation on DRG development at later stages. We
therefore crossed TetO-YAP mice with those expressing rtTA under
the control of the Sox10 promoter (Sox10-rtTA) (Ludwig et al.,
2004), which is ﬁrst turned-on in migratory NC cells around E8.5
and stays active in DRG progenitors and the glial lineage during
DRG development. Dox administration starting from E7.5 led to
increased YAP levels in Sox10þ DRG progenitors and glia in the
DRG of TetO-YAP;Sox10-rtTA embryos at E12.5 (Fig. 4A and B).
These DRG contained signiﬁcantly more Sox10þp75þ DRG pro-
genitors (Fig. 4C–E, arrowheads) and Sox10þp75– glia (Fig. 4C–D0
and F, arrows) than did control DRG. The number of Isl1/2þ
neurons, however, was unperturbed at either E12.5 (Fig. 4G–I) or
E11.5 (Fig. S1A–E). Furthermore, the numbers of each subtype of
neurons were similar between control and TetO-YAP;Sox10-rtTA
DRG (Fig. S1F–L). Thus, YAP hyperactivation in Sox10þ NC cells
expands the DRG progenitor and glial populations but does not
affect neurogenesis.
To examine the effect of YAP overexpression in the glial lineage
speciﬁcally, we started Dox delivery at E12.5, when most Sox10þ
cells in control embryos have differentiated into the glial lineage
(Fig. 4E and F; 14 DRG progenitors vs. 100 glia in control
embryos) (Hu et al., 2011). At E18.5, YAP was overexpressed in
Sox10þ cells in TetO-YAP;Sox10-rtTA DRG (Fig. 4J–K0) and almost all
Sox10þ cells expressed the glial marker S100β (Fig. 4L–M0). We
quantiﬁed the number of glia by counting Sox10þ cells. TetO-YAP;
Sox10-rtTA DRG contained signiﬁcantly more glial cells at E18.5
than did controls (Fig. 4N). These results demonstrate that aber-
rant YAP activation in glial cells causes overexpansion of this
population.
Nf2 is expressed in the developing DRG
So far, our data demonstrate that Yap/Taz are expressed in DRG
progenitors and glial cells during normal DRG development and
that aberrant YAP activation in these cells causes overexpansion of
these cell populations. We next sought to identify upstream
regulators of Yap/Taz. We hypothesized that Nf2 is an inhibitor
of Yap during DRG development. The Nf2 transcript is widely
expressed during mouse embryogenesis (Gutmann et al., 1995;
Huynh et al., 1996), and high levels of Nf2 promoter activity are
seen in migrating NC cells (Akhmametyeva et al., 2006). We
performed immunostaining to monitor the expression and locali-
zation of Nf2 proteins in the developing DRG. At E10.5, Nf2
proteins were detected in the soma of Sox10þ DRG progenitors
and glial precursors (Fig. 5A and A0, arrowheads) and in the soma
and processes of Tuj1þ sensory neurons (Fig. 5A and A0, arrows).
At E12.5, Nf2 was present in Blbpþ satellite glia (Fig. 5B–D; arrows
and arrowheads mark three examples of glial processes) and
Tuj1þ sensory neurons (Fig. 5E and E0). Thus, Nf2 is expressed in
all cell types in the developing DRG and is coexpressed with Yap/
Taz in DRG progenitors and the glial lineage (see Fig. 1).
Loss of Nf2 leads to similar defects in DRG development as does YAP
hyperactivation
To test our hypothesis that Nf2 is an inhibitor of Yap during
DRG development, we conditionally deleted Nf2 in the NC lineage
using Wnt1-Cre, which is expressed in NC precursors in the dorsal
neural tube starting from E8.5 (Danielian et al., 1998). We
conﬁrmed that Nf2 proteins were no longer detected in Nf2 cKO
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(Nf2Flox/Δ;Wnt1-Cre) DRG at E13.5, the earliest stage we could collect
sufﬁcient amount of tissues for western blot analysis (Fig. 5F).
Because YAP overexpression affected DRG progenitors, we ﬁrst
examined the effect of Nf2 deletion on this population. At E10.5, the
number of Sox10þp75þ DRG progenitors was signiﬁcantly increased
in Nf2 cKO embryos (Fig. 6A–C). The percentage of proliferating DRG
progenitors within the progenitor population, measured by BrdU
incorporation after a 2-h pulse (BrdUþSox10þp75þ/Sox10þp75þ
cells), was also signiﬁcantly increased (Fig. 6D– F), whereas cell-cycle
exit during the 24-h period between E9.5 and E10.5 was reduced
(BrdUþKi67–/BrdUþ cells) (Fig. 6G–I). At E12.5, most Sox10þ cells in
both control and Nf2 cKO DRG no longer expressed p75 (Fig. 6J–K0,
arrows), and the numbers of Sox10þp75þ DRG progenitors in control
and Nf2 cKO DRG were similar (Fig. 6L). These phenotypes closely
Fig. 2. YAP overexpression in NC precursors, migratory NC cells, and DRG progenitors expands the DRG progenitor pool. Dox-containing water was given to pregnant females
starting from E5.5 and embryos were collected at E10.5 and E12.5. (A–D0) At E10.5, YAP is overexpressed in Sox10þ cells in TetO-YAP;Axin2-rtTA DRG. C, C0 and D, D0 are
magniﬁed views of the boxed regions in A and B, respectively. Arrowheads: Sox10þp75þ DRG progenitors; arrows: Sox10þp75 glial precursors. (E and F) At E12.5, YAP is
no longer overexpressed in TetO-YAP;Axin2-rtTA DRG. (G–I) The number of Sox10þp75þ DRG progenitors is increased in TetO-YAP;Axin2-rtTA DRG compared to controls.
Panels labeled with primes are the magniﬁed view of the boxed areas in corresponding panels. (J–L) Quantiﬁcation of BrdUþ cells among Sox10þp75þ DRG progenitors after
a 2-h BrdU pulse shows increased proliferation of DRG progenitors in TetO-YAP;Axin2-rtTA embryos. Arrowheads: BrdUþ DRG progenitors; arrows: BrdU– DRG progenitors.
(M–O) Quantiﬁcation of Ki67– cells among BrdUþ cells after a 24-h BrdU pulse shows decreased cell-cycle exit in TetO-YAP;Axin2-rtTA DRG. Arrowheads: BrdUþKi67 cells;
arrows: BrdUþKi67þ cells. nPo0.05, nnPo0.01. Scale bars: 50 μm in A, E, G, J and M; 25 μm in C0 , G0, J0 and M0 .
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resemble those of TetO-YAP;Axin2-rtTA embryos (see Fig. 2G–O), thus
supporting our hypothesis that Nf2 is a Yap inhibitor during DRG
development.
We next analyzed gliogenesis and neurogenesis in Nf2 cKO
DRG. Glia are Sox10þBlbpþ at E12.5 and Sox10þS100βþ at E18.5
(Fig. 6M–P). We quantiﬁed glia by counting Sox10þ cells at these
stages. This approach gives a close estimate of the quantity of glial
cells because, from E12.5 and onward, Sox10þp75þ DRG progeni-
tors constitute less than 5% of the cells in DRG and their numbers
were similar in control and Nf2 cKO DRG (Fig. 6J–L0). At E12.5 and
E18.5, the number of glia was signiﬁcantly increased in Nf2 cKO
DRG (Fig. 6Q). The number of neurons, marked by Isl1/2 at E10.5
and Tuj1 at E18.5, was reduced in Nf2 cKO DRG (Fig. 7A–E). At
E10.5, the numbers of TrkBþ and TrkCþ neurons were signiﬁcantly
reduced but the number of TrkAþ neurons was unchanged
(Fig. 7F–L). At E18.5, the numbers of all three subtypes of neurons
were reduced in Nf2 cKO DRG (Fig. 7M–S). The expansion in the
glial population at E12.5 and E18.5 and reduction in neuron
numbers at E10.5 in Nf2 cKO DRG resembles the effects of YAP
overexpression (see Figs. 2–4), reinforcing our hypothesis that Nf2
is a Yap inhibitor in the developing DRG.
Yap deletion rescues Nf2 cKO phenotypes in DRG
To further conﬁrm that Nf2 functions by inhibiting Yap, we
generated Nf2 and Yap double cKO animals (Nf2Flox/Δ;Wnt1-Cre;YapFlox/Flox,
herein called Nf2;Yap cKO). Yap cKO (YapFlox/Flox;Wnt1-Cre) and Nf2;
Yap cKO embryos all died around E10.5 with massive forebrain
bleeding (data not shown), probably due to defects in cerebral
vessel formation. We therefore focused our analyses at E10.5. Yap
deletion alone in the NC lineage did not affect DRG progenitor
(Fig. 8A, B and E) or neuronal populations (Fig. 8F, G and J).
However, deletion of Yap in the Nf2 cKO background suppressed
the expansion of DRG progenitors (Fig. 8A and C–E) and rescued the
reduction in the neuronal population (Fig. 8F and H–J). These results
strongly support that Nf2 is an inhibitor of Yap during DRG
development.
Fig. 3. YAP overexpression in NC precursors, migratory NC cells, and DRG progenitors leads to a transient reduction in neuron number. (A–G) The number of neurons is
reduced in TetO-YAP;Axin2-rtTA DRG at E10.5 but not changed at P0. Neurons are labeled by Isl1/2 at E10.5 and Tuj1 at P0. At P0, YAP is no longer overexpressed in TetO-YAP;
Axin2-rtTA DRG (C and D). (H–N) At E10.5, the number of TrkCþ neurons is reduced but the numbers of TrkAþ and TrkBþ neurons are unchanged in TetO-YAP;Axin2-rtTA DRG.
(O–U) At P0, the numbers of each subtype of neurons are unchanged in TetO-YAP;Axin2-rtTA DRG. nPo0.05, nnPo0.01. Scale bars: 50 μm in A, H, J and L; 100 μm in C, E, O,
Q and S.
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Nf2–Yap signaling controls the expansion of sympathetic ganglia (SG)
progenitors
So far we have shown that Nf2–Yap signaling controls the
expansion of DRG progenitors. Since Yap/Taz are expressed in
migrating NC cells at E9.5 (Fig. 1A), we asked whether progenitors
in other NC derivatives are also regulated by Nf2–Yap signaling. To
this end, we examined the development of SG, which are a part of
the autonomic nervous system that regulates the homeostasis of
the internal environment of the organism (Rohrer, 2011). In control
SG, Yap/Taz were expressed in Sox10þ SG progenitors (Fig. 9A) but
not in Isl1/2þ sympathetic neuroblasts (data not shown). In the
Fig. 4. YAP overexpression in DRG progenitors and glial cells expands these populations. (A–I) Dox-containing water was given to pregnant females starting from E7.5 and
embryos were collected at E12.5. (A and B) YAP is overexpressed in Sox10þ cells in E12.5 TetO-YAP;Sox10-rtTA DRG. (C–F) At E12.5, TetO-YAP;Sox10-rtTA DRG have more
Sox10þp75þ DRG progenitors (arrowheads in C0 and D0) and Sox10þp75– glia (arrows in C0 and D0) compared to controls. Panels labeled with primes are the magniﬁed view
of the boxed areas in corresponding panels. (G–I) The number of Isl1/2þ neurons is not changed in TetO-YAP;Sox10-rtTA DRG at E12.5. (J–N) Dox-containing water was given
to pregnant females starting from E12.5 and embryos were collected at E18.5. (J–K0) YAP is overexpressed in Sox10þ cells in E18.5 TetO-YAP;Sox10-rtTA DRG. (L–M0) Almost all
Sox10þ cells express the glial marker S100β. (N) The number of glial cells, quantiﬁed by counting Sox10þ cells, is increased in TetO-YAP;Sox10-rtTA DRG compared to controls.
nPo0.05, nnPo0.01, nnnPo0.001. Scale bars: 50 μm in A, C, G, J0 and L0; 25 μm in C0; 100 μm in J, L.
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aforementioned TetO-Yap;Axin2-rtTA double transgenic embryos
(Dox starting from E5.5), YAP was overexpressed in Sox10þ SG
progenitors at E10.5 (Fig. 9A and B). At this stage, the SG of TetO-Yap;
Axin2-rtTA embryos contained signiﬁcantly more Sox10þ SG pro-
genitors (Fig. 9C–E). The percentage of proliferating SG progenitors
within the progenitor population, measured by BrdU incorporation
after a 2-h pulse (BrdUþSox10þ/Sox10þ cells), was also markedly
increased (Fig. 9F–H). Nf2 deletion in NC cells led to similar pheno-
types as YAP hyperactivation. At E10.5, the SG progenitor population
was expanded in Nf2 cKO embryos (Fig. 9I–K). The fraction of
proliferating SG progenitors was markedly higher in Nf2 cKO embryos
than in controls (Fig. 9L–N). Finally, although Yap deletion alone did
not affect the SG progenitor population (Fig. 9O, P and S), it suppressed
the expansion of SG progenitors in the Nf2 cKO background (Fig. 9O
and Q–S). These results demonstrate that Nf2–Yap signaling controls
the expansion of SG progenitors.
Discussion
The Hippo pathway is recently recognized as a crucial regulator of
tissue growth and tumorigenesis. Here we show that, during
mammalian DRG development, the key effectors of this pathway,
transcriptional coactivators Yap/Taz, are expressed in DRG progeni-
tors and glia but not in the neuronal lineage. The cytoplasmic
localization of Yap/Taz proteins and the presence of the inactive,
phosphorylated form of Yap indicate that their transcriptional
activities are at least partially inhibited. We show that aberrant
YAP activation leads to overexpansion of the DRG progenitor and glial
populations. We further identiﬁed that Nf2 is an inhibitor of Yap
in the developing DRG; Nf2 cKO embryos exhibit similar phenotypes
as those with elevated YAP activity and these phenotypes are
suppressed by Yap deletion. Our study demonstrates that Nf2–
Yap/Taz signaling is an important regulator of mammalian DRG
development.
Nf2–Yap signaling regulates the proliferation of DRG progenitors
Our YAP gain-of-function experiments using the TetO-YAP
transgenic mouse line demonstrate that aberrant YAP activation
in DRG progenitors promotes their proliferation and over-expands
the progenitor pool. Loss of Nf2 in the NC lineage leads to nearly
identical phenotypes. Furthermore, deleting Yap in the Nf2 cKO
background suppresses overexpansion of the DRG progenitor pool.
These results strongly suggest that Nf2–Yap signaling controls the
size of the progenitor pool during normal DRG development.
It is unclear whether YAP overactivation promotes the main-
tenance of the multipotent state of DRG progenitors as it does in
mouse embryonic stem cells (Lian et al., 2010). Moreover, it
remains an open question whether Yap/Taz are required for
normal DRG development. The early lethality of YapFlox/Flox;Wnt1-
Cre embryos prevented us from thoroughly investigating Yap’s role
during DRG development. Nevertheless, our preliminary analysis
of E10.5 YapFlox/Flox;Wnt1-Cre DRG did not reveal any obvious
defects. It is quite possible that Taz may compensate for the loss
of Yap. Future studies using Yap;Taz Wnt1-Cre double cKO
embryos, Yap or Yap;Taz cKO with Cre lines that act either at later
stages or in more restricted lineages (e.g., Sox10-Cre (Matsuoka
et al., 2005) and Plp-CreERT2 (Hari et al., 2012; Leone et al., 2003)),
and neural crest stem cell cultures (Morrison et al., 2000; Paratore
et al., 2001; Paratore et al., 2002; Taylor et al., 2007) prepared from
Fig. 5. Nf2 is expressed in the developing DRG. (A and A0) At E10.5, Nf2 is detected in the soma of Sox10þ DRG progenitors and glia (arrowheads) and in the soma and
processes of Tuj1þ neurons (arrows). Panels labeled with primes are the magniﬁed view of the boxed areas in corresponding panels. (B–D) At E12.5, Nf2 is detected in Blbpþ
satellite glia. Arrows and arrowheads point to three examples of glial processes. (E and E0) At E12.5, Nf2 is expressed in Tuj1þ neurons. (F) Western blot analysis shows that
Nf2 is no longer detected in E13.5 Nf2 cKO DRG. Scale bars: 50 μm in A, B and E; 10 μm in A0 , B0 and E0.
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gain- and loss-of-function mutant embryos will provide more
insights into the function of Yap/Taz during DRG development.
One phenotypic difference between Nf2 cKO and YAP gain-of-
function mutants is that, although overexpressing YAP using the
Sox10-rtTA line is able to over-expand the DRG progenitor popula-
tion at E12.5, Nf2 deletion fails to do so (compare Fig. 4E vs.
Fig. 6L). We think this difference is likely because the level of Yap
activation achieved by Nf2 deletion is lower than that obtained by
YAP overexpression. We were unable to detect, by immunostain-
ing, increased Yap/Taz nuclear localization in Nf2 cKO DRG (data
not shown), which is likely because the change is too small to be
quantitatively detected by immunostaining. Previously, we were
able to detect increased Yap/Taz nuclear localization in Nf2 cKO
brains by subcellular fractionation and quantitative western blot
analysis (Lavado et al., 2013). This approach, however, is not feasible
for analyzing DRG samples because the tissue amount is too limited.
The functions of Yap and Nf2 during DRG gliogenesis
By selectively elevating YAP level in the glial lineage of DRG, we
show that YAP hyperactivation over-expands the glial population,
probably by increasing the proliferation of glial precursors. Nf2
cKO mice exhibit a similar phenotype. Although the phenotypic
similarity suggests that, as in DRG progenitors, Nf2 regulates Yap
activity, we cannot yet prove this genetically due to the early
lethality of YapFlox/Flox;Wnt1-Cre embryos. It remains possible that
Nf2 functions independently of Yap/Taz during glia development.
Indeed, previous studies have shown that Nf2 regulates CNS glial
cell proliferation by inhibiting ErbB2-dependent Src signaling
(Houshmandi et al., 2009) and Schwann cell proliferation and
function through a number of signaling pathways (Li et al., 2012;
McClatchey and Giovannini, 2005). These possibilities need to be
addressed by more molecular and genetic studies in the future.
Fig. 6. Loss of Nf2 leads to similar defects in DRG development as does YAP hyperactivation. (A–C) At E10.5, Nf2 cKO DRG have more Sox10þp75þ DRG progenitors than
controls. Panels labeled with primes are the magniﬁed view of the boxed areas in corresponding panels. (D–F) Quantiﬁcation of BrdUþ cells among Sox10þp75þ DRG
progenitors after a 2-h BrdU pulse shows increased proliferation in Nf2 cKO. Arrowheads: BrdUþ DRG progenitors; arrows: BrdU– DRG progenitors. (G–I) Quantiﬁcation of
Ki67– cells among BrdUþ cells after a 24-h BrdU pulse shows decreased cell-cycle exit in Nf2 cKO. Arrowheads: BrdUþKi67 cells; arrows: BrdUþKi67þ cells. (J–L0) At E12.5,
the number of Sox10þp75þ DRG progenitors and the percentage of DRG progenitors among all DRG DAPIþ cells (DAPI staining not shown) in Nf2 cKO are similar to that in
controls. Arrows: Sox10þp75 glial cells. (M–Q) The number of glial cells is increased in Nf2 cKO DRG at E12.5 and E18.5. Glia are Sox10þBlbpþ at E12.5 and Sox10þS100βþ
at E18.5. nPo0.05, nnPo0.01. Scale bars: 50 μm in A, D, G and J, M; 25 μm in A0 , D0 , G0 and J0; 100 μm in O.
Y. Serinagaoglu et al. / Developmental Biology 398 (2015) 97–109 105
The functions of Yap and Nf2 during DRG neurogenesis
In addition to the effects on DRG progenitor and glial popula-
tions, YAP gain-of-function and Nf2 loss also affect the amount of
DRG sensory neurons. The mutant phenotypes are quite complex.
TetO-YAP;Axin2-rtTA mice show a transient reduction of early born
TrkCþ neurons at E10.5 but, by P0, neuron numbers are restored to
normal levels. TetO-YAP;Sox10-rtTA mice, with Dox administration
starting from E7.5, do not exhibit neuron number defects at E11.5
or E12.5. Nf2 cKO mice, however, exhibit reductions of early born
Fig. 7. Deletion of Nf2 leads to a reduction in neurons. (A–E) The number of neurons, marked by Isl1/2 at E10.5 and by Tuj1 at E18.5, is reduced in Nf2 cKO DRG. (F–L) The
numbers of TrkBþ and TrkCþ neurons are reduced but the number of TrkAþ neurons is not changed in Nf2 cKO DRG at E10.5. (M–S) The numbers of each subtype of neurons
are reduced in Nf2 cKO DRG at E18.5. nPo0.05, nnPo0.01. Scale bars: 50 μm in A, F, H and J; 100 μm in C, M, O and Q.
Fig. 8. Yap deletion rescues the early DRG defects of Nf2 cKO embryos. Yap deletion alone does not affect the numbers of Sox10þp75þ DRG progenitors (A, B and E) and Isl1/
2þ neurons (F, G and J). However, it suppresses the expansion of DRG progenitors (A–E) and reduction in neurons (F–J) in Nf2 cKO DRG. nPo0.05, nnPo0.01, n.s., not
signiﬁcant. Scale bars: 50 μm.
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TrkBþ neurons and TrkCþ neurons at E10.5 and reductions of all
subtypes of neurons at E18.5. Deleting Yap in the Nf2 cKO back-
ground restores the total number of neurons at E10.5. Based on
these results, we postulate the following.
The genetic rescue experiment indicates that, at least before
E10.5, Nf2 regulates DRG neurogenesis by inhibiting Yap. Only
neurons born during the ﬁrst wave of neurogenesis are affected in
TetO-YAP;Axin2-rtTA and Nf2 cKO embryos, suggesting that Nf2–
Yap signaling probably selectively regulates the ﬁrst wave of
neurogenesis but not the second wave. We have examined Ngn2
and Ngn1 expression in YAP gain-of-function and Nf2 cKO mutants
but did not detect obvious differences in their expression patterns
or levels (Fig. S2). It is possible that Nf2–Yap signaling regulates a
neuronal differentiation step downstream of Ngn2 expression, for
example the upregulation of NeuroD or Isl1/2.
It is interesting and somewhat puzzling that our two YAP gain-of-
function mouse models display different neurogenesis phenotypes:
TetO-YAP;Axin2-rtTA but not TetO-YAP;Sox10-rtTA embryos exhibit a
delay in neurogenesis. The key difference between these two models
is the timing of rtTA expression: Axin2-rtTA expression starts in NC
precursors within the neural tube (Yu et al., 2007), whereas Sox10-
rtTA expression starts in migratory NC cells (Kuhlbrodt et al., 1998).
Our results thus suggest that YAP hyperactivation has to occur very
early during DRG development to have an impact on neurogenesis.
This might explain why only TrkCþ neurons are affected in TetO-YAP;
Axin2-rtTA embryos, as they are the ﬁrst subtype of neurons to be
born during DRG development (Ma et al., 1999). Accumulating
evidence suggests that at least some NC precursors within the neural
tube are already pre-speciﬁed into lineage-restricted subpopulations
(George et al., 2007; Lefcort and George, 2007; Nitzan et al., 2013). It
is thus possible that elevated Yap activity alters the relative propor-
tion of these subpopulations of multipotent NC cells in the neural
tube, for example by converting one subpopulation into another or
by preferentially promoting the production of one subpopulation. It
is also possible that elevated Yap activity promotes proliferative
divisions of multipotent DRG progenitors, which then transition into
glial precursors to generate glia, thus reducing neuron production,
although we think this is less likely considering that TetO-YAP;Sox10-
rtTA embryos do not exhibit neurogenesis defects. Lastly, the differ-
ence in the mode of action by Axin2-rtTA, which leads to transient
overexpression mainly in multipotent NC cells, and Wnt1-Cre, which
causes permanent gene deletion, might account for the difference
between TetO-YAP;Axin2-rtTA DRG (reduction of TrkCþ neurons only)
and Nf2 cKO DRG (reductions of both TrkBþ and TrkCþ neurons). In
summary, more detailed in vivo lineage-tracing experiments are
required to address these possibilities.
An important phenotypic difference between Nf2 cKO mutants
and YAP gain-of-functions mutants is that, at the end of embry-
ogenesis, the numbers of sensory neurons are reduced in Nf2 cKO
mutants but are normal in YAP gain-of-function mutants. These
results indicate that, during the later stages of DRG development,
Nf2’s function in sensory neurons is independent of Yap/Taz
(which are not expressed in sensory neurons). Nf2 loss might
impair the proliferation of neuronal precursors or the survival of
Fig. 9. Nf2–Yap signaling controls the expansion of SG progenitors. (A–H) Dox-containing water was given to pregnant females starting from E5.5 and embryos were
collected at E10.5. (A and B) At E10.5, YAP is overexpressed in Sox10þ cells in TetO-YAP;Axin2-rtTA SG. (C–E) The number of Sox10þ SG progenitors is increased in TetO-YAP;
Axin2-rtTA SG compared to controls. (F–H) Quantiﬁcation of BrdUþ cells among Sox10þ SG progenitors after a 2-h BrdU pulse shows increased proliferation of SG progenitors
in TetO-YAP;Axin2-rtTA embryos. Arrowheads: BrdUþ SG progenitors; arrows: BrdU– SG progenitors. (I–K) At E10.5, Nf2 cKO SG have more Sox10þ SG progenitors than
controls. (L–N) Quantiﬁcation of BrdUþ cells among Sox10þ SG progenitors after a 2-h BrdU pulse shows increased proliferation in Nf2 cKO SG. Arrowheads: BrdUþ SG
progenitors; arrows: BrdU– SG progenitors. (O–S) Yap deletion alone does not affect the number of Sox10þ SG progenitors. However, it suppresses the expansion of SG
progenitors in Nf2 cKO SG. nnPo0.01, n.s., not signiﬁcant. Scale bars: 50 μm.
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DRG neurons. The exact function of Nf2 in DRG neurons needs to
be determined by future studies. Interestingly, a recent work
found that, in neurons of both the CNS and the peripheral
nervous system (PNS), including in DRG neurons, Nf2 promotes
neuroﬁlament phosphorylation by activating the GTPase RhoA
and thereby is essential for maintaining axonal integrity (Schulz
et al., 2013).
Conclusions
By using YAP gain-of-function and Nf2 loss-of-function mouse
models, we demonstrate that Nf2–Yap signaling regulates the develop-
ment of two NC derivatives, the DRG and the SG. The observation that
signiﬁcant amount of Yap/Taz proteins remain localized in the cyto-
plasm in Nf2 cKO DRG (see above, data not shown) suggests that other
factors are involved in sequestering Yap/Taz in the cytoplasm. Consis-
tent with this idea, although the TetO-YAP transgenic animals used here
express the S127A mutant form of YAP (Camargo et al., 2007),
which is thought to have increased nuclear localization than the
wild-type protein because it cannot be inhibited by the Hippo kinase
cascade (Yu and Guan, 2013), a large fraction of YAP-S127A proteins
reside in the cytoplasm (see Fig. 2B and D and Fig. 4B, K and K0),
indicating that factors besides the Hippo kinase cascade are involved in
Yap/Taz suppression during DRG development. A rapidly growing list of
Yap/Taz regulators are being discovered (Yu and Guan, 2013). An
important task for future studies is to understand how these regulators
operate in intact animals.
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